117 related articles for article (PubMed ID: 9055038)
1. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3'-exonuclease.
Koziołkiewicz M; Wójcik M; Kobylańska A; Karwowski B; Rebowska B; Guga P; Stec WJ
Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):43-8. PubMed ID: 9055038
[TBL] [Abstract][Full Text] [Related]
2. Stereo-enriched phosphorothioate oligodeoxynucleotides: synthesis, biophysical and biological properties.
Yu D; Kandimalla ER; Roskey A; Zhao Q; Chen L; Chen J; Agrawal S
Bioorg Med Chem; 2000 Jan; 8(1):275-84. PubMed ID: 10968287
[TBL] [Abstract][Full Text] [Related]
3. P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
Krieg AM; Guga P; Stec W
Oligonucleotides; 2003; 13(6):491-9. PubMed ID: 15025915
[TBL] [Abstract][Full Text] [Related]
4. Stereodifferentiation--the effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H.
Koziolkiewicz M; Krakowiak A; Kwinkowski M; Boczkowska M; Stec WJ
Nucleic Acids Res; 1995 Dec; 23(24):5000-5. PubMed ID: 8559657
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic assignment of diastereomeric purity of stereodefined phosphorothioate oligonucleotides.
Koziołkiewicz M; Owczarek A; Gendaszewska E
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):171-81. PubMed ID: 10355823
[TBL] [Abstract][Full Text] [Related]
6. Stereocontrolled synthesis of oligonucleoside phosphorothioates and PO/PS-chimeric oligonucleotides by using oxazaphospholidine derivatives.
Oka N; Yamamoto M; Sato T; Wada T
Nucleic Acids Symp Ser (Oxf); 2008; (52):335-6. PubMed ID: 18776390
[TBL] [Abstract][Full Text] [Related]
7. The effect of divalent cations on the catalytic activity of the human plasma 3'-exonuclease.
Wojcik M; Stec WJ
Biometals; 2010 Dec; 23(6):1113-21. PubMed ID: 20589414
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside alpha-thiotriphosphates, polymerases and the exonuclease III analysis of oligonucleotides containing phosphorothioate linkages.
Yang Z; Sismour AM; Benner SA
Nucleic Acids Res; 2007; 35(9):3118-27. PubMed ID: 17452363
[TBL] [Abstract][Full Text] [Related]
10. Impact of 3'-exonuclease stereoselectivity on the kinetics of phosphorothioate oligonucleotide metabolism.
Gilar M; Belenky A; Budman Y; Smisek DL; Cohen AS
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):35-42. PubMed ID: 9512094
[TBL] [Abstract][Full Text] [Related]
11. Effect of phosphorothioate chirality on i-motif structure and stability.
Kanaori K; Sakamoto S; Yoshida H; Guga P; Stec W; Tajima K; Makino K
Biochemistry; 2004 May; 43(19):5672-9. PubMed ID: 15134441
[TBL] [Abstract][Full Text] [Related]
12. Stereodefined phosphorothioate analogues of DNA: relative thermodynamic stability of the model PS-DNA/DNA and PS-DNA/RNA complexes.
Boczkowska M; Guga P; Stec WJ
Biochemistry; 2002 Oct; 41(41):12483-7. PubMed ID: 12369839
[TBL] [Abstract][Full Text] [Related]
13. Effect of P-chirality of oligo(deoxyribonucleoside phosphorothioate)s on the activity of terminal deoxyribonucleotidyl transferase.
Koziołkiewicz M; Maciaszek A; Stec WJ; Semizarov D; Victorova L; Krayevsky A
FEBS Lett; 1998 Aug; 434(1-2):77-82. PubMed ID: 9738455
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of phosphorothioate oligonucleotides with stereodefined phosphorothioate linkages.
Guga P; Stec WJ
Curr Protoc Nucleic Acid Chem; 2003 Oct; Chapter 4():Unit 4.17. PubMed ID: 18428907
[TBL] [Abstract][Full Text] [Related]
15. Stereocontrolled solid-phase synthesis of phosphorothioate oligoribonucleotides using 2'-O-(2-cyanoethoxymethyl)-nucleoside 3'-O-oxazaphospholidine monomers.
Nukaga Y; Yamada K; Ogata T; Oka N; Wada T
J Org Chem; 2012 Sep; 77(18):7913-22. PubMed ID: 22931131
[TBL] [Abstract][Full Text] [Related]
16. Solid support synthesis of all-Rp-oligo(ribonucleoside phosphorothioate)s.
Almer H; Stawinski J; Strömberg R
Nucleic Acids Res; 1996 Oct; 24(19):3811-20. PubMed ID: 8871563
[TBL] [Abstract][Full Text] [Related]
17. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
18. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
[TBL] [Abstract][Full Text] [Related]
19. Phosphorothioate oligonucleotide-directed triple helix formation.
Hacia JG; Wold BJ; Dervan PB
Biochemistry; 1994 May; 33(18):5367-9. PubMed ID: 8180158
[TBL] [Abstract][Full Text] [Related]
20. Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates).
Stec WJ; Grajkowski A; Koziolkiewicz M; Uznanski B
Nucleic Acids Res; 1991 Nov; 19(21):5883-8. PubMed ID: 1945876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
